163 related articles for article (PubMed ID: 23871851)
1. In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6 months of treatment in skeletally mature beagle dogs.
Aref M; Gallant MA; Organ JM; Wallace JM; Newman CL; Burr DB; Brown DM; Allen MR
Bone; 2013 Oct; 56(2):449-53. PubMed ID: 23871851
[TBL] [Abstract][Full Text] [Related]
2. Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model.
Allen MR; McNerny E; Aref M; Organ JM; Newman CL; McGowan B; Jang T; Burr DB; Brown DM; Hammond M; Territo PR; Lin C; Persohn S; Jiang L; Riley AA; McCarthy BP; Hutchins GD; Wallace JM
PLoS One; 2017; 12(8):e0181750. PubMed ID: 28793321
[TBL] [Abstract][Full Text] [Related]
3. Reference point indentation is insufficient for detecting alterations in traditional mechanical properties of bone under common experimental conditions.
Krege JB; Aref MW; McNerny E; Wallace JM; Organ JM; Allen MR
Bone; 2016 Jun; 87():97-101. PubMed ID: 27072518
[TBL] [Abstract][Full Text] [Related]
4. In Vivo UTE-MRI Reveals Positive Effects of Raloxifene on Skeletal-Bound Water in Skeletally Mature Beagle Dogs.
Allen MR; Territo PR; Lin C; Persohn S; Jiang L; Riley AA; McCarthy BP; Newman CL; Burr DB; Hutchins GD
J Bone Miner Res; 2015 Aug; 30(8):1441-4. PubMed ID: 25644867
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate.
Meixner CN; Aref MW; Gupta A; McNerny EMB; Brown D; Wallace JM; Allen MR
Calcif Tissue Int; 2017 Jul; 101(1):75-81. PubMed ID: 28246928
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene enhances vertebral mechanical properties independent of bone density.
Allen MR; Iwata K; Sato M; Burr DB
Bone; 2006 Nov; 39(5):1130-1135. PubMed ID: 16814622
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra.
Allen MR; Gineyts E; Leeming DJ; Burr DB; Delmas PD
Osteoporos Int; 2008 Mar; 19(3):329-37. PubMed ID: 18094911
[TBL] [Abstract][Full Text] [Related]
8. In vivo reference point indentation measurement variability in skeletally mature inbred mice.
Srisuwananukorn A; Allen MR; Brown DM; Wallace JM; Organ JM
Bonekey Rep; 2015; 4():712. PubMed ID: 26131362
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms.
Surowiec RK; Saldivar R; Rai RK; Metzger CE; Jacobson AM; Allen MR; Wallace JM
Bone; 2023 Aug; 173():116805. PubMed ID: 37196853
[TBL] [Abstract][Full Text] [Related]
10. Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta.
Berman AG; Wallace JM; Bart ZR; Allen MR
Matrix Biol; 2016; 52-54():19-28. PubMed ID: 26707242
[TBL] [Abstract][Full Text] [Related]
11. Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone.
Allen MR; Hogan HA; Hobbs WA; Koivuniemi AS; Koivuniemi MC; Burr DB
Endocrinology; 2007 Aug; 148(8):3908-13. PubMed ID: 17478550
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease.
Newman CL; Creecy A; Granke M; Nyman JS; Tian N; Hammond MA; Wallace JM; Brown DM; Chen N; Moe SM; Allen MR
Kidney Int; 2016 Jan; 89(1):95-104. PubMed ID: 26489025
[TBL] [Abstract][Full Text] [Related]
13. Modulation of bone turnover in orchidectomized rats treated with raloxifene and risedronate.
Khedr NF; El-Ashmawy NE; El-Bahrawy HA; Haggag AA; El-Abd EE
Fundam Clin Pharmacol; 2013 Oct; 27(5):526-34. PubMed ID: 22762129
[TBL] [Abstract][Full Text] [Related]
14. Variations in nanomechanical properties and tissue composition within trabeculae from an ovine model of osteoporosis and treatment.
Burket JC; Brooks DJ; MacLeay JM; Baker SP; Boskey AL; van der Meulen MC
Bone; 2013 Jan; 52(1):326-36. PubMed ID: 23092698
[TBL] [Abstract][Full Text] [Related]
15. Variability of in vivo reference point indentation in skeletally mature inbred rats.
Allen MR; Newman CL; Smith E; Brown DM; Organ JM
J Biomech; 2014 Jul; 47(10):2504-7. PubMed ID: 24856912
[TBL] [Abstract][Full Text] [Related]
16. Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment.
Allen MR; Reinwald S; Burr DB
Calcif Tissue Int; 2008 May; 82(5):354-60. PubMed ID: 18463913
[TBL] [Abstract][Full Text] [Related]
17. Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs.
Allen MR; Kubek DJ; Burr DB
J Bone Miner Res; 2010 Jan; 25(1):98-105. PubMed ID: 19580463
[TBL] [Abstract][Full Text] [Related]
18. Reference-point indentation correlates with bone toughness assessed using whole-bone traditional mechanical testing.
Gallant MA; Brown DM; Organ JM; Allen MR; Burr DB
Bone; 2013 Mar; 53(1):301-5. PubMed ID: 23274349
[TBL] [Abstract][Full Text] [Related]
19. Insights into reference point indentation involving human cortical bone: sensitivity to tissue anisotropy and mechanical behavior.
Granke M; Coulmier A; Uppuganti S; Gaddy JA; Does MD; Nyman JS
J Mech Behav Biomed Mater; 2014 Sep; 37():174-85. PubMed ID: 24929851
[TBL] [Abstract][Full Text] [Related]
20. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.
Allen MR; Burr DB
J Bone Miner Res; 2007 Nov; 22(11):1759-65. PubMed ID: 17663638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
